10-Q: Donaldson Q2 Earnings Mixed Amid Acquisition, Sales Growth

Donaldson Company reports mixed second-quarter results with increased net sales and diluted EPS for the six-month period, but a slight dip in quarterly net earnings, while announcing a significant acquisition.

Summary

• Net sales for the three months ended January 31, 2026, increased by 3.0% to $896.3 million, and for the six months, increased by 3.5% to $1,831.7 million.
• Net earnings for the three months decreased by 3.6% to $92.5 million, while for the six months, net earnings increased by 5.9% to $206.4 million.
• Diluted EPS for the three months was $0.78, a slight decrease from $0.79, but for the six months, it increased by 9.3% to $1.75.
• Gross margin as a percentage of net sales decreased to 33.5% for the three months (from 35.2%) and to 34.3% for the six months (from 35.3%), primarily due to operational inefficiencies and footprint optimization costs.
• The company entered into a definitive agreement to acquire Filtration Group's Facet Filtration business for approximately $820 million in an all-cash transaction, expected to close in about six months.
• The Life Sciences segment showed strong growth, with net sales increasing by 16.2% for the three months and 14.6% for the six months, and a significant improvement from losses to earnings before income taxes.
• The U.S. Supreme Court issued a decision on February 20, 2026, concluding that the International Emergency Economic Powers Act does not provide authority for the President to impose tariffs, which the company is evaluating for potential impact on previously paid tariffs.
• Restructuring and related expenses for the six months ended January 31, 2026, were $5.1 million, with estimated future costs of $10.0 million to $15.0 million through fiscal 2026.
• The net cash cycle increased to 95 days as of January 31, 2026, from 85 days as of July 31, 2025, indicating less efficient working capital management.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report, balancing strong six-month performance and strategic acquisition with a slight quarterly earnings dip and operational challenges impacting gross margin.

Positives

• Net sales increased by 3.0% for the three months to $896.3 million and by 3.5% for the six months to $1,831.7 million, driven by favorable foreign currency impacts and pricing benefits.
• Net earnings for the six months ended January 31, 2026, increased by 5.9% to $206.4 million, and diluted EPS increased by 9.3% to $1.75.
• The Life Sciences segment demonstrated significant improvement, moving from a loss of $5.8 million in earnings before income taxes for the six months ended January 31, 2025, to earnings of $14.7 million in the current period, with sales growth of 14.6%.
• The Mobile Solutions segment's Aftermarket sales increased by $34.2 million for the six months, driven by market share gains and higher vehicle utilization rates in EMEA and APAC.
• A gain on the sale of fixed assets of $9.3 million was recognized for the six months ended January 31, 2026, related to footprint optimization initiatives.
• Research and development expenses decreased by 11.7% for the three months and 13.7% for the six months, reflecting focused project prioritization.
• The effective tax rate decreased to 20.7% for the three months and 21.8% for the six months, primarily due to an increase in excess tax benefits on stock-based compensation.
• The company repurchased 1.4 million shares for $108.6 million during the six months, demonstrating a commitment to returning capital to shareholders.
• Dividends paid increased to $0.60 per common share for the six months ended January 31, 2026, up from $0.54 per share in the prior year.

Negatives

• Net earnings for the three months ended January 31, 2026, decreased by 3.6% to $92.5 million from $95.9 million in the prior year.
• Diluted EPS for the three months ended January 31, 2026, decreased by 1.3% to $0.78 from $0.79.
• Gross margin as a percentage of net sales decreased to 33.5% for the three months (from 35.2%) and to 34.3% for the six months (from 35.3%), primarily due to operational inefficiencies related to shifting Power Generation equipment production and footprint optimization costs.
• Interest expense increased significantly by 29.0% for the three months to $7.7 million and by 30.4% for the six months to $14.8 million, reflecting a higher proportion of variable interest rate debt and overall higher debt levels.
• Sales volume declined for both the three and six months ended January 31, 2026, partially offsetting favorable foreign currency impacts and pricing benefits.
• The Industrial Solutions segment's earnings before income taxes decreased by 22.8% for the six months to $63.2 million, driven by operational inefficiencies and unfavorable business unit sales mix.
• The net cash cycle increased by 10 days to 95 days, with days sales outstanding increasing to 67 from 62 and days inventory outstanding increasing to 84 from 75, indicating a less efficient use of working capital.

Risks

• The Facet acquisition integration activities may involve complex operational, financial, and cultural alignment efforts, potentially leading to increased operating costs, reduced financial performance, or disruptions.
• The Facet acquisition involves inherent risks of liabilities, including potential litigation and regulatory matters, and there may be undisclosed liabilities that prove more costly than anticipated.
• Changes in international trade policy, including tariffs and export controls, pose ongoing risks to global supply chains, potentially increasing costs, straining procurement cycles, and impacting customer demand.
• Impacts of global economic, industrial, and political conditions on product demand, including unexpected events, unavailable raw materials, significant demand fluctuations, or material cost changes.
• Inability to attract and retain qualified personnel, which could affect the company's operations and growth.
• Threats from disruptive technologies and highly competitive markets with pricing pressure could adversely affect the company's competitive advantages and profitability.
• Vulnerabilities associated with information technology systems and security, including cybersecurity risks.
• Inability to protect and enforce intellectual property rights, which are crucial for the company's technology-led filtration products.
• Costs associated with governmental laws and regulations, including environmental and tax regulations.
• Impacts of foreign currency fluctuations on international net sales and net earnings.
• Effects of changes in capital and credit markets on the company's ability to access financing and manage debt obligations.

Future Outlook

The company expects the acquisition of Facet Filtration business to close in approximately six months, subject to customary closing conditions including regulatory approvals, and plans to finance it with a combination of cash on hand and new debt. It will continue global footprint and cost optimization actions through fiscal 2026, with estimated future costs of $10.0 million to $15.0 million. The company is also evaluating the impact of the recent U.S. Supreme Court tariff ruling on future reporting periods and will adopt new FASB accounting standards for income statement expense disaggregation and income tax disclosures in fiscal years 2028/2029 and 2026/2027, respectively.

Management Comments

• The company is closely monitoring the evolving trade landscape, as well as its ability to mitigate the impact of tariffs and its analysis of the potential impact.
• The company will continue to utilize its global manufacturing footprint and supply chain to mitigate the cost impact of tariffs.
• The company strives to recover or offset all material cost increases through price increases to its customers and the company’s cost reduction initiatives, which include material substitution, process improvement and product redesigns.

Industry Context

StockSavvy.ai notes that the filtration industry continues to see demand driven by specialized applications in aerospace, defense, and life sciences, as evidenced by Donaldson's strategic Facet acquisition and strong Life Sciences segment growth. The company's diversification across Mobile, Industrial, and Life Sciences segments helps mitigate risks from cyclical industries, a common strategy among diversified industrial players. The ongoing global trade policy uncertainties, particularly regarding tariffs, remain a significant external factor impacting supply chains and costs across the manufacturing sector.

Comparison to Industry Standards

• The filing does not provide specific comparisons to other companies, projects, or global benchmarks within the industry.

Corporate Governance

Legal Proceedings

• The company records provisions for claims and litigation when a liability is probable and estimable, and believes its estimated liability is adequate and appropriate.
• It is considered remote that the settlement of any currently identified claims or litigation will be materially in excess of what is accrued.

Related Party Transactions

• The company holds a 50% ownership in Advanced Filtration Systems Inc. (AFSI) with Caterpillar Inc., and guarantees half of AFSI's outstanding debt, which was $36.7 million as of January 31, 2026.
• The company holds a 30% ownership in PT Panata Jaya Mandiri (PTPJM).
• The company holds a 49% non-controlling stake in Medica S.p.A., acquired on August 9, 2024, with an option to acquire the remaining 51% in three years.
• The financial impact from these joint ventures and non-controlling interest is not material.

Stakeholder Impact

• Shareholders are impacted by the mixed financial results, including a quarterly net earnings decrease but a six-month diluted EPS increase, along with increased dividends and ongoing share repurchases.
• Employees may be affected by ongoing global footprint and cost optimization actions, which include restructuring charges, while the Facet acquisition will add approximately 250 employees.
• Customers will benefit from the expansion of product offerings and market reach through the acquisition of Facet Filtration, particularly in aerospace, defense, and power generation solutions.
• Creditors face increased exposure due to the rise in long-term debt and the company's expectation to incur additional debt to finance the Facet acquisition, though the company remains in compliance with financial covenants.

Next Steps

• Closing of the Facet Filtration acquisition, expected in approximately six months, pending regulatory approvals.
• Evaluation of the impact of the U.S. Supreme Court tariff ruling on future reporting periods and potential recoveries of previously paid tariffs.
• Continued monitoring of the evolving trade landscape and implementation of strategies to mitigate tariff impacts.
• Adoption of ASU 2024-03 (Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures) for fiscal 2028 annual and fiscal 2029 interim reporting.
• Adoption of ASU 2023-09 (Income Taxes – Improvements to Income Tax Disclosures) for fiscal 2026 annual and fiscal 2027 interim reporting.
• Continued global footprint and cost optimization actions through fiscal 2026, with estimated future costs of $10.0 million to $15.0 million.
• Potential exercise of the option to acquire the remaining 51% stake in Medica S.p.A. in three years.

Key Dates

Recommendation

The company demonstrates resilience with overall sales growth and a strong performance in its Life Sciences segment, coupled with a strategic acquisition that expands its market reach. However, the decline in quarterly net earnings, contraction in gross margin due to operational inefficiencies, and an increase in the net cash cycle suggest underlying challenges. The planned debt for the acquisition and ongoing tariff uncertainties introduce additional considerations. Given the mixed financial signals and the integration risks of a large acquisition, a 'hold' recommendation is appropriate as investors await clearer execution on the acquisition and improvements in operational efficiency.

Keywords

Filtration, Industrial Solutions, Mobile Solutions, Life Sciences, Aerospace, Defense, Power Generation, Aftermarket, SEC Filing, Earnings, Acquisition, Tariffs, DCI, Quarterly Report